Study of the Acceptability and Psychosocial Impact of Using a Telepresence Robot in the Living Space of Inpatients
ROBOLINK-e
1 other identifier
interventional
49
1 country
4
Brief Summary
This study focuses on the mobile robot assist device for tele-interaction: the "COVEALINK 2" robot. This telepresence robot is designed for remote use inside the home. It works with an Internet connection (Wifi or 4G). It consists of a control interface (an application installed on the smartphone or tablet of the hospitalized patient) and a mobile robot placed in the home of the hospitalized patient (composed of a mobile platform, a visualization screen whose tilt is adjustable remotely for better adaptation to the interlocutors and an audio communication system). From the app installed on his smartphone or tablet, the patient hospitalized in the center for a long time (2 months minimum) will be able to start remotely (from the center where he is hospitalized) the robot and have it move within his home to communicate with the people present at the time of use (family, friends, neighbors etc.).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2020
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 24, 2020
CompletedFirst Submitted
Initial submission to the registry
May 10, 2021
CompletedFirst Posted
Study publicly available on registry
May 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 18, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 18, 2024
CompletedMarch 6, 2026
February 1, 2020
3.2 years
May 10, 2021
March 5, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluation of the medium-term acceptance of robotic tele-interaction
Measured with hospitalized patients using questionnaires developed by the LP3C (Laboratory of Psychology, Cognition, Behavior, Communication)
At 2 months
Secondary Outcomes (12)
Evaluation of the a priori acceptability of robotic tele-interaction
Day 0
Evaluation of the short-term acceptance of robotic tele-interaction
At 1 month
Measure the effects of the use of the telepresence device on the patient's perception of his environment and his psycho-thymic state.
Day 0
Measure the effects of the use of the telepresence device on the patient's perception of his environment and his psycho-thymic state.
Day 0
Measure the effects of the use of the telepresence device on the patient's perception of his environment and his psycho-thymic state.
Day 0
- +7 more secondary outcomes
Study Arms (1)
Installation of a telepresence robot in the home of a disabled person hospitalized in a PRM center
EXPERIMENTALFrom the application installed on a tablet, the patient hospitalized in a center for a period of at least 2 months can start from the center where he is hospitalized the mobile robotic telepresence assistance device installed at home to communicate with his family, his friends, his neighbors,…)
Interventions
From the application installed on a tablet, the patient hospitalized in a center for a period of at least 2 months can start from the center where he is hospitalized the mobile robotic telepresence assistance device installed at home to communicate with his family, his friends, his neighbors,…)
Eligibility Criteria
You may qualify if:
- Age ≧ 18 years old
- Affiliation to a social security scheme or beneficiary of such a scheme
- Having signed a free informed consent in writing
- Hospitalized in PRM for a foreseeable period of at least 60 days
- Living space compatible with the movement of the robot (verified by a home visit by the center's occupational therapist) and equipped with wifi
- Cognitive and motor functions compatible with the use of the tablet or phone independently, with learning capabilities to use the robot and the completion of questionnaires and interviews remotely
- Medically stable
You may not qualify if:
- Mood and behavior disorders not stabilized
- Insufficient command of the French language
- Protected adults (guardianship / curatorship)
- Pregnant or breastfeeding women
- Persons deprived of their liberty
- Being unable to issue their consent
- Person who has already presented a form of addiction to technologies and / or video games
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Association APPROCHElead
- LP3C, University of Rennes 2collaborator
- COVEAcollaborator
Study Sites (4)
CR Mulhouse
Mulhouse, Alsace, 68100, France
IUR Clémenceau
Strasbourg, Alsace, 67000, France
CMRRF de Kerpape
Ploemeur, Brittany Region, 56270, France
CMPR Côte d'Amour
Saint-Nazaire, Pays de la Loire Region, 44600, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thibaud Honoré, Doctor
CMRRF de Kerpape
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 10, 2021
First Posted
May 25, 2021
Study Start
October 24, 2020
Primary Completion
January 18, 2024
Study Completion
April 18, 2024
Last Updated
March 6, 2026
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share